miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2

Cuilan Wang1, Bo Liu2

  • 1Department of Gynaecology and Obstetrics, Jinan Maternity and Child Care Hospital, No. 2 Xiaojingsan Road, Jinan, 250001, Shandong, China. bseuguo@163.com.

Abstract

Insights

MicroRNA-101-3p promotes autophagy in endometrial carcinoma (EC) cells by downregulating EZH2. This finding reveals a new therapeutic target for EC treatment by modulating miR-101-3p and EZH2.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Endometrial carcinoma (EC) is a common gynecological malignancy.
  • Autophagy plays a complex role in cancer development and progression.
  • The role of microRNAs (miRNAs) in regulating cellular processes in EC is an active area of research.

Purpose of the Study:

  • To investigate the role of miR-101-3p in regulating autophagy in endometrial carcinoma (EC) cells.
  • To explore the relationship between miR-101-3p and EZH2 in EC.

Main Methods:

  • Microarray analysis for miRNA expression.
  • Western blot for autophagy-related proteins.
  • qRT-PCR for beclin-1 mRNA expression.
  • GFP-LC3 fusion protein assay and fluorescence microscopy for autophagy observation.
  • Transmission electron microscopy (TEM) for autophagic vacuoles.
  • Luciferase reporter assay to confirm miR-101-3p and EZH2 interaction.

Main Results:

  • miR-101-3p expression was decreased in EC tissues compared to normal tissues.
  • miR-101-3p overexpression upregulated autophagy-related proteins LC3-II and beclin-1 in EC cells.
  • Both miR-101-3p overexpression and EZH2 silencing promoted autophagy in EC cells.
  • Luciferase assays confirmed that miR-101-3p directly targets and inhibits EZH2 by binding to its 3'-UTR.

Conclusions:

  • miR-101-3p promotes autophagy in EC cells through the downregulation of EZH2.
  • Suppression of EZH2 expression by miR-101-3p is a key mechanism for inducing autophagy in EC.
  • Modulating miR-101-3p levels could be a potential therapeutic strategy for endometrial carcinoma.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.9K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.6K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Induced-fit Model01:13

Induced-fit Model

Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
89.7K